1887
  1. Home
  2. BSAVA Small Animal Formulary Part A: Canine and Feline
  3. Ondansetron
Ondansetron
; https://doi.org/
/content/dataitem/canine-and-feline/ondansetron

Ondansetron

Online Access: Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition. 
  1. Sedlacek HS ,Ramsey DS ,Boucher JF et al. (2008)Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. Journal of Veterinary Pharmacology and Therapeutics 31 ,533–537
  2. Yalcin E and Keser GO (2017) Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.Journal of Veterinary Pharmacology and Therapeutics 40, 599–560
  3. Burke JE, Hess RS and Silverstein DC (2021) Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.Journal of the American Veterinary Medical Association 260, S40–S45
    4.
  4. Burrows CF (1990) Ondansetron: a new drug to control nausea and emesis in cancer patients.Veterinary Clinical Briefs 8, 3
    5.
  5. Fitzpatrick RL, Wittenburg LA, Hansen RJ et al. (2016) Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease.Journal of Veterinary Pharmacology and Therapeutics  39, 350–355
    6.
  6. Foth S, Meller S, Kenward H et al. (2021) The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.BMC Veterinary Research 17, 222
    7.
  7. Jensen TN, Nielsen J, Frederiksen K and Ebert B (2006) Molecular cloning and pharmacological characterisation of serotonin 5-HT(3) receptor subtype in dog.European Journal of Pharmacology 538, 23 – 31
    8.
  8. Kenward H, Elliott J, Lee T and Pelligand L (2017) Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.BMC Veterinary Researc h 13, 244
    9.
  9. Kopke MA, Wightman P and Ruaux CG (2019) Obstructive sleep apnea in a Chihuahua successfully managed with ondansetron.Clinical Case Reports 7, 872 – 876
    10.
  10. Quimby JM, Lake RC, Hansen RJ et al. (2014) Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats.Journal of Veterinary Pharmacology and Therapeutics  37, 348–353
    11.
  11. Santos LC, Ludders JW, Erb HN et al.(2011) A randomized, blinded, controlled trial of the antiemetic effect of ondansetron on dexmedetomidine-induced emesis in cats.Veterinary Anaesthesia and Analgesia 38, 320–327
    12.
  12. Sullivan LA, Lenberg JP, Boscan P et al.(2018) Assessing the efficacy of maropitant versus ondansetron in the treatment of dogs with parvoviral enteritis.Journal of the American Animal Hospital Association 54, 338–343
    13.
  13. Trepanier L (2010) Acute vomiting in cats: rational treatment selection.Journal of Feline Medicine and Surgery 12, 225–230
    14.
  14. Zajic LB, Herndon AK, Sieberg LG et al. (2017) Assessment of absorption of transdermal ondansetron in normal research cats.Journal of Feline Medicine and Surgery  19, 1245–1248
    15.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error